The clinical pharmacology of appetite suppressant drugs.
One way of gaining a greater understanding of the central mechanisms underlying hunger and the regulation of feeding behaviour in humans is to examine the actions and interactions on hunger and food intake of drugs with known or presumed pharmacological modes of action. To this end we have undertaken a number of studies which fall into three main categories: the mechanisms by which amphetamine anorexia is induced; the possible role of endogenous opioids in feeding; the action of amino acids thought to be involved in the regulation of feeding. In this field the potential for cross-fertilization between basic scientists working with laboratory animals and clinical scientists working with human subjects exists. For example, the clinical pharmacologist has been able to test out hypotheses on human subjects which could only have been developed using laboratory animals. Furthermore, using human subjects it is possible to extend the field of inquiry into an exploration of the subjective dimensions of appetite and hunger.
D000818:Animals; D001066:Appetite / Q000187:drug effects*; D001067:Appetite Depressants / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D004723:Endorphins / Q000494:pharmacology; D005247:Feeding Behavior / Q000187:drug effects*; D006801:Humans; D013948:Moxisylyte / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D010649:Phenylalanine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D014364:Tryptophan / Q000494:pharmacology
D001067:Appetite Depressants; D004723:Endorphins; D012701:Serotonin; D010649:Phenylalanine; D014364:Tryptophan; D011433:Propranolol; D013948:Moxisylyte; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine